News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: TUI delivers strong preliminary FY 2025 results above expectations with underlying EBIT growth of +12.6% exceeding guidance of +9-11% at constant currency
TUI AG delivers strong preliminary FY 2025 results with underlying EBIT growth of +12.6%, exceeding guidance of +9-11% at constant currency. Record performance in Hotels & Resorts and Cruises -
-
PRESS RELEASE
Loar Holdings Inc. Reports Q3 2025 Record Results and Upward Revisions to 2025 Outlook and Full Year 2026 Outlook
Loar Holdings Inc. reports record Q3 2025 results with $126.8M net sales, $27.6M net income, and raised 2025 & 2026 outlook. CEO Dirkson Charles comments on the strong performance in commercial aviation and defense markets -
-
-
PRESS RELEASE
Fineqia Cross-Lists Bitcoin Yield ETP (YBTC) and FTSE Cardano Enhanced Yield ETN (YADA) on gettex
Fineqia cross-lists Bitcoin Yield ETP and FTSE Cardano Enhanced Yield ETN on gettex, Munich Stock Exchange, for European investors with DeFi opportunities. CFO Warren Sergeant discusses benefits -
PRESS RELEASE
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
New data from Telomir Pharmaceuticals show Telomir-1 effectively modulates iron levels in human keratinocytes, key for its epigenetic mechanism. Telomir-1 provides strong intracellular iron reduction surpassing Deferoxamine